ATE269859T1 - Prodigiosin-derivate zur bekämpfung von krebs und virus-bedingten krankheiten - Google Patents

Prodigiosin-derivate zur bekämpfung von krebs und virus-bedingten krankheiten

Info

Publication number
ATE269859T1
ATE269859T1 AT01902193T AT01902193T ATE269859T1 AT E269859 T1 ATE269859 T1 AT E269859T1 AT 01902193 T AT01902193 T AT 01902193T AT 01902193 T AT01902193 T AT 01902193T AT E269859 T1 ATE269859 T1 AT E269859T1
Authority
AT
Austria
Prior art keywords
virus
related diseases
fight cancer
prodigiosin
derivatives
Prior art date
Application number
AT01902193T
Other languages
English (en)
Inventor
Madiraju S R Murthy
Nancy A E Steenaart
Roy A Johnson
Gordon C Shore
Original Assignee
Gemin X Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gemin X Biotechnologies Inc filed Critical Gemin X Biotechnologies Inc
Application granted granted Critical
Publication of ATE269859T1 publication Critical patent/ATE269859T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01902193T 2000-01-26 2001-01-24 Prodigiosin-derivate zur bekämpfung von krebs und virus-bedingten krankheiten ATE269859T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/491,712 US6407244B1 (en) 2000-01-26 2000-01-26 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
PCT/CA2001/000085 WO2001055131A2 (en) 2000-01-26 2001-01-24 Prodigiosin-derivatives as neoplastic and anti-viral agents

Publications (1)

Publication Number Publication Date
ATE269859T1 true ATE269859T1 (de) 2004-07-15

Family

ID=23953337

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01902193T ATE269859T1 (de) 2000-01-26 2001-01-24 Prodigiosin-derivate zur bekämpfung von krebs und virus-bedingten krankheiten

Country Status (19)

Country Link
US (2) US6407244B1 (de)
EP (2) EP1431286A3 (de)
JP (1) JP2003523352A (de)
KR (1) KR20020072295A (de)
CN (1) CN1419553A (de)
AT (1) ATE269859T1 (de)
AU (1) AU780647B2 (de)
BR (1) BR0107912A (de)
CA (1) CA2398173A1 (de)
CZ (1) CZ20022604A3 (de)
DE (1) DE60103978D1 (de)
IL (1) IL150817A0 (de)
MX (1) MXPA02007271A (de)
NO (1) NO20023486L (de)
NZ (1) NZ520361A (de)
PL (1) PL356932A1 (de)
SK (1) SK10952002A3 (de)
WO (1) WO2001055131A2 (de)
ZA (1) ZA200205838B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407244B1 (en) 2000-01-26 2002-06-18 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
US20040014987A1 (en) * 2000-01-26 2004-01-22 Gemin X Biotechnologies Inc. Pyrrole-Type compounds, compositions, and methods for treating cancer or viral diseases
DE60223571T2 (de) * 2001-07-18 2008-07-24 Gemin X Pharmaceuticals Canada. Inc., Montreal Verbindungen vom pyrroltyp, zusammensetzungen und verfahren zur behandlung von krebs, zur behandlung von virenerkrankungen und zur unterdrückung der immunreaktion
US20030119894A1 (en) * 2001-07-20 2003-06-26 Gemin X Biotechnologies Inc. Methods for treatment of cancer or neoplastic disease and for inhibiting growth of cancer cells and neoplastic cells
AU2003280437A1 (en) * 2002-06-27 2004-01-19 Microport Medical (Shanghai) Co., Ltd. Drug eluting stent
ES2382377T3 (es) * 2003-05-30 2012-06-07 Gemin X Pharmaceuticals Canada Inc. Compuestos triheterocíclicos, composiciones, y métodos para tratar cáncer
US8420693B2 (en) * 2004-12-28 2013-04-16 Gemin X Pharmaceuticals Canada Inc. Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases
JP2010533205A (ja) * 2007-07-12 2010-10-21 トラガラ ファーマシューティカルズ,インク. 癌、腫瘍、および腫瘍関連障害を治療するための方法および組成物
EP2224919A4 (de) * 2007-11-28 2011-09-14 Tragara Pharmaceuticals Inc Verfahren und zusammensetzungen zur behandlung von krebs, tumoren und tumor-bedingten erkrankungen
CN103145719B (zh) * 2013-02-27 2015-04-29 中国科学院化学研究所 灵菌红素衍生物的制备方法
US10322123B2 (en) 2014-09-29 2019-06-18 The Penn State Research Foundation Compound for anti-cancer therapy that acts by targeting GOF mutant P53 and stimulates P73 to restore the P53 pathway signaling
US10314320B2 (en) 2015-03-20 2019-06-11 Meltz, LLC Systems for controlled liquid food or beverage product creation
US10111554B2 (en) 2015-03-20 2018-10-30 Meltz, LLC Systems for and methods of controlled liquid food or beverage product creation
KR101785428B1 (ko) 2016-04-21 2017-10-16 (주) 마이크로프랜드 반도체소자 테스트소켓
JP2020517400A (ja) 2017-04-27 2020-06-18 コミティア,インク. 遠心分離抽出のための方法および本方法を実行するために好適な装置
CN109942559A (zh) * 2019-03-08 2019-06-28 上海大学 呋喃二联吡咯化合物及其制备方法
US11724849B2 (en) 2019-06-07 2023-08-15 Cometeer, Inc. Packaging and method for single serve beverage product
EP4789664A1 (de) * 2025-02-10 2026-08-12 Universite De Bordeaux Neuartige antiretrovirale verbindungen und deren verwendungen

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4266028A (en) * 1979-02-21 1981-05-05 Kirin Beer Kabushiki Kaisha Process for preparation of prodigiosin
JPS55162768A (en) * 1979-06-06 1980-12-18 Kirin Brewery Co Ltd Carcinostatic
JPS6134403A (ja) 1984-07-26 1986-02-18 Nec Corp 光干渉計
JPS61280429A (ja) 1985-06-06 1986-12-11 Chugai Pharmaceut Co Ltd 免疫抑制剤
JPH02250828A (ja) 1989-03-23 1990-10-08 Nippon Kayaku Co Ltd 新規免疫抑制剤
JPH0586374A (ja) 1991-09-26 1993-04-06 Teikoku Sekiyu Kk 炭水化物を可燃性のガスに分解する方法
GB9326284D0 (en) 1993-12-23 1994-02-23 Erba Carlo Spa Pyrrolydenemethyl-derivatives and process for their preparation
JPH0930967A (ja) 1995-07-17 1997-02-04 Chugai Pharmaceut Co Ltd 抗潰瘍剤
GB9603212D0 (en) 1996-02-15 1996-04-17 Pharmacia Spa Process for the preparation of 2,2'-bipyrrolyl-pyrromethane derivatives
GB9619706D0 (en) 1996-09-20 1996-11-06 Pharmacia Spa Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole comp und
JP3949196B2 (ja) 1996-10-23 2007-07-25 赤穂化成株式会社 免疫抑制剤
JP3949198B2 (ja) 1996-10-23 2007-07-25 赤穂化成株式会社 V−ATPase 脱共役 H+ ポンプ阻害剤
GB9705035D0 (en) 1997-03-11 1997-04-30 Pharmacia & Upjohn Spa Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
KR100252197B1 (ko) 1997-09-20 2000-04-15 박호군 세라시아 마르세센스 균주의 배양액으로 부터 분리한 면역억제제용 프로디지오신
JPH11209283A (ja) 1997-10-01 1999-08-03 Ako Kasei Co Ltd 抗癌剤
GB9726130D0 (en) 1997-12-10 1998-02-11 Pharmacia & Upjohn Spa 2,2'-BI-1H-pyrrole derivatives useful in the treatment of leukemia brought on by HTLV-I
GB9802745D0 (en) 1998-02-09 1998-04-08 Pharmacia & Upjohn Spa Benzyloxy prodigiosine compounds
US6407244B1 (en) 2000-01-26 2002-06-18 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases

Also Published As

Publication number Publication date
CA2398173A1 (en) 2001-08-02
NZ520361A (en) 2004-02-27
NO20023486L (no) 2002-09-04
JP2003523352A (ja) 2003-08-05
PL356932A1 (en) 2004-07-12
EP1431286A2 (de) 2004-06-23
SK10952002A3 (sk) 2003-01-09
DE60103978D1 (de) 2004-07-29
BR0107912A (pt) 2002-12-10
EP1255753B1 (de) 2004-06-23
MXPA02007271A (es) 2004-07-30
AU2991201A (en) 2001-08-07
CN1419553A (zh) 2003-05-21
EP1255753A2 (de) 2002-11-13
CZ20022604A3 (cs) 2003-01-15
NO20023486D0 (no) 2002-07-22
US20030009032A1 (en) 2003-01-09
AU780647B2 (en) 2005-04-07
ZA200205838B (en) 2004-03-08
WO2001055131A3 (en) 2002-03-07
US6602879B2 (en) 2003-08-05
IL150817A0 (en) 2003-02-12
US6407244B1 (en) 2002-06-18
EP1431286A3 (de) 2004-07-28
KR20020072295A (ko) 2002-09-14
WO2001055131A2 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
DE60103978D1 (de) Prodigiosin-derivate zur bekämpfung von krebs und virus-bedingten krankheiten
ATE361287T1 (de) Neue indol-2-on derivate
ATE484494T1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
EA200500853A1 (ru) 2,4,6-тризамещённые пиримидины, являющиеся ингибиторами фосфотидилинозитол(pi)-3-киназы, и их применение при лечении рака
NO20045656L (no) Oftalmologisk anvendelse av roflumilast for behandlingen av oyesykdommer
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
SE9903544D0 (sv) Novel compounds
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
SE0104341D0 (sv) New use
EA200401114A3 (ru) Замещённые гидроксиэтиламины
ATE367387T1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
EE200200143A (et) 4-bensüülaminokinoliini konjugaadid sapphappega ja nende heteroanaloogid, nende valmistamismeetod ning neid ühendeid sisaldavad ravimid ja nende kasutamine
DK1255734T3 (da) Hidtil ukendte isatin-derivater
EA200400219A1 (ru) Производные хинолина и их использование в качестве противоопухолевых средств
HUP0402654A2 (hu) 2-[(2'-Halogén-3',5'-dialkoxi-fenil)-imino]-imidazolidin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
SE0004827D0 (sv) Therapeutic compounds
EE200200660A (et) Akrüloüüldistamütsiini derivaati sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritudravimpreparaat
DE69910706D1 (de) Medikament zur Behandlung von Glaukoma und ischämischer Retinopathie
ATE301997T1 (de) Antivirale therapie
DE69908855D1 (de) 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin
ATE270886T1 (de) Antivirale therapie
ATE430752T1 (de) Neue indenoä2,1-aüindene und isoindolä2,1-aüindol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties